Posters
- Home
- Education Events
- Posters
- Serum vedolizumab and corresponding anti-vedolizumab antibody: Analysis of over 6500 patient results using lab developed chemiluminescent immunoassays (ECLIA)
Serum vedolizumab and corresponding anti-vedolizumab antibody: Analysis of over 6500 patient results using lab developed chemiluminescent immunoassays (ECLIA)
12 Dec 2019
Published in: AIBD (Advances in Inflammatory Bowel Diseases)
Authors:
- Kelly Y. Chun
- Phagoo S
- Metushi I
- Kelemen M
- Eby J
- Yang JM